David J. Mauro, Chief Medical Officer at Prelude Therapeutics Inc (PRLD), sold 17,941 shares at $39.56 ($687K) on 2021-04-08, disclosed to the SEC on 2021-04-15.
Open-market sale of $687k PRLD by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.04 | 3,274 | $121K | 17.6% |
| 2 | $37.04 | 3,274 | $121K | 17.6% |
| 3 | $37.83 | 1,501 | $57K | 8.3% |
| 4 | $37.83 | 1,501 | $57K | 8.3% |
| 5 | $39.00 | 1,293 | $50K | 7.3% |
| 6 | $39.56 | 3,549 |
| $140K |
| 20.4% |
| 7 | $39.56 | 3,549 | $140K | 20.4% |
| Total | $38.31 avg | 17,941 | $687K | 100% |
| Filing → |
| PRLD | SELL | 2021-08-09 | $930K | — | Filing → |
| PRLD | SELL | 2021-07-08 | $816K | — | Filing → |
| PRLD | SELL | 2021-06-09 | $902K | — | Filing → |